ImmunityBio (IBRX) Long-Term Investments (2014 - 2023)
ImmunityBio (IBRX) reported Long-Term Investments of $891000.0 for Q4 2023, up 6.07% year-over-year from $840000.0 in Q4 2022, and up 9.06% quarter-over-quarter from $817000.0 in Q3 2023.
ImmunityBio (IBRX) Long-Term Investments (2014 - 2023) Analysis & Trends
ImmunityBio (IBRX) has 10 years of Long-Term Investments data on file, last reported at $891000.0 in Q4 2023.
- Long-Term Investments for Q4 2023 came in at $891000.0, up 6.07% year-over-year; the trailing twelve-month figure through Dec 2023 was $891000.0 (up 6.07% YoY), and the FY2023 annual result was $891000.0, up 6.07% from the prior year.
- Long-Term Investments improved to $891000.0 in Q4 2023 per IBRX's latest filing, from $817000.0 in the prior quarter.
- Over five years, Long-Term Investments peaked at $9.3 million in Q2 2020 and troughed at $769000.0 in Q3 2020.
- A 5-year average of $2.8 million and a median of $865000.0 in 2022 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2019 and 2020: Long-Term Investments surged 1221.86% in 2019, then plunged 91.69% in 2020.
- A 5-year view of Long-Term Investments shows it stood at $9.3 million in 2019, then sank by 89.73% to $950000.0 in 2020, then fell by 13.47% to $822000.0 in 2021, then gained by 2.19% to $840000.0 in 2022, then grew by 6.07% to $891000.0 in 2023.
- Business Quant data shows IBRX's Long-Term Investments at $891000.0 in Q4 2023, $817000.0 in Q3 2023, and $841000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 891,000.00 |
| Sep 30, 2023 | 817,000.00 |
| Jun 30, 2023 | 841,000.00 |
| Mar 31, 2023 | 820,000.00 |
| Dec 31, 2022 | 840,000.00 |
| Sep 30, 2022 | 811,000.00 |
| Jun 30, 2022 | 914,000.00 |
| Mar 31, 2022 | 865,000.00 |
| Dec 31, 2021 | 822,000.00 |
| Sep 30, 2021 | 802,000.00 |
| Jun 30, 2021 | 822,000.00 |
| Mar 31, 2021 | 1.00 Mn |
| Dec 31, 2020 | 950,000.00 |
| Sep 30, 2020 | 769,000.00 |
| Jun 30, 2020 | 9.30 Mn |
| Dec 31, 2019 | 9.25 Mn |
| Sep 30, 2019 | 9.25 Mn |
| Jun 30, 2019 | 9.25 Mn |
| Mar 31, 2019 | 4.19 Mn |
| Dec 31, 2018 | 700,000.00 |